Loading
Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | OM SHANTI MEDICOS | 1 | ₹21,951 |
| 2 | Schedule 3 | GOYAL PHARMACEUTICALS | 1 | ₹2,214 |
| 3 | Schedule 4 | VINDECA LIFE SCIENCES PRIVATE LIMITED | 1 | ₹594 |
| 4 | Schedule 5 | SUNIL PHARMACY | 1 | ₹13,754 |
Tender Value
₹93,209
EMD Value
Exempted
Closing Date
7 May 2024, 4:00 pmClosed
Bethanechol 25mg tab
Tacrolimus eye Oint
Hydrocortisone 5mg tab
Phenobarbitone 30mg tab
Levosulpiride 25mg tab BOQ Title ECHS DRUGS CFA RE BOQ 02
6313988
GEM/2024/B/4862885
Two Packet Bid
Bethanechol 25mg tab,Tacrolimus eye Oint,Hydrocortisone 5mg tab,Phenobarbitone 30mg tab,Levosulpiri
15 days
Delhi; Central Delhi
Item wise evaluation
BOQ
8 documents required · 8 mandatory
3 yrs
10%
Exempted
7 May 2024
15 Apr 2024
7 May 2024
| Item No | Item Title | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|
| 1 | Bethanechol 25mg tab | 8,100 | No | Central Delhi | 15 |
| 2 | Tacrolimus eye Oint | 152 | Tube | Central Delhi | 15 |
| 3 | Hydrocortisone 5mg tab | 900 | No | Central Delhi | 15 |
| 4 | Phenobarbitone 30mg tab | 600 | No | Central Delhi | 15 |
| 5 | Levosulpiride 25mg tab | 29,900 | No | Central Delhi | 15 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_6313988.pdf
GEM_BID
echs_boq_cfa_re-02_list_of_medicine_2024-04-15-15-36-55_948dac72076a69e05ea622782719361c.pdf
BOQ
boq_list_of_medicine_cfa_re-02_2024-04-15-15-36-55_17162f220229bb2b498e4a11dffc67d8.csv
BOQ
AtcDoc_73ed760a-be6f-4417-b8051713176364899_soharabmudgil.500a@gov.in.pdf
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .